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dria to provide a stable intracellular niche 
for replication (Luhrmann and Roy, 2007). 
The pathogen also activates Akt and Erk1/2 
signaling to promote survival (Voth and 
Heinzen, 2009). Each of these events relies 
on Coxiella protein synthesis, suggesting 
the organism secretes a distinct effector(s) 
to regulate apoptosis. Unfortunately, effec-
tor identification and characterization has 
been hampered by a lack of methods for 
Coxiella genetic manipulation. As an alter-
native, Luhrmann et al. (2010) investigated 
the mechanistic activity of a Coxiella Ank 
through exploration of its anti-apoptotic 
function in Legionella.
Luhrmann et al. (2010) tested the abil-
ity of four Anks (AnkA, B, F, and G) to 
inhibit intrinsic apoptosis. Eukaryotic cells 
ectopically expressing individual Anks 
were treated with the apoptosis-inducing 
agent staurosporine. Only AnkG prevented 
apoptosis with ∼65% of AnkG-expressing 
cells maintaining viability. Ankyrin repeat 
domains mediate eukaryotic protein– 
protein interactions (Mosavi et al., 2004) 
and Dot/Icm substrates predictably bind to, 
and manipulate, a specific host protein(s). 
Therefore, Luhrmann et al. (2010) used 
GST pulldown and immunoprecipita-
tion approaches to identify host-binding 
partners for AnkG. Interestingly, mass 
spectrometry analysis and confirmatory 
immunoprecipitation studies identified 
the mitochondrial inner matrix protein 
p32 as a specific AnkG interacting protein. 
p32 is a pro-apoptotic protein that binds 
to Hrk to promote cytochrome c release 
(Sunayama et al., 2004) and also interacts 
with ARF, a pro-apoptotic p53 regulatory 
protein (Itahana and Zhang, 2008). Thus, 
AnkG interaction with p32 likely precludes 
interaction with other pro-apoptotic mito-
chondrial proteins, resulting in decreased 
cytochrome c release. This is also the first 
known example of a bacterial protein tar-
geting p32 to manipulate host cell survival.
Next, the authors performed a set of 
interesting gain of function experiments. 
In contrast to Coxiella, Legionella induces 
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Intracellular bacterial pathogens have devel-
oped strategies to subvert numerous host 
cell processes, often by deploying a battery 
of secreted proteins, termed effectors, into 
the cytosol. The stealthy agent of Q fever, 
Coxiella burnetii, continuously manipu-
lates its eukaryotic host cell throughout a 
prolonged infectious cycle and replicates 
in a unique phagolysosome-like vacuole. 
The organism encodes a Dot/Icm type IV 
secretion system (T4SS) similar to that of 
closely related Legionella pneumophila, the 
causative agent of Legionnaires’ disease 
(Seshadri et al., 2003). These pathogens’ 
respective T4SSs are predicted to translo-
cate a large number of effectors directly 
from the vacuole into the host cell cytosol 
where they interact with eukaryotic pro-
teins to influence infection events. While 
over 300 Legionella Dot/Icm substrates have 
been identified (Hubber and Roy, 2010), 
Coxiella encodes few obvious homologs of 
these or other bacterial effectors, indicat-
ing the use of pathogen-specific repertoires. 
However, T4SS conservation allows the use 
of Legionella to study Coxiella effectors, 
expanding the panel of tools available for 
this genetically intractable organism.
Recent studies show Coxiella isolates 
encode 14 Ank proteins containing eukary-
otic-like ankyrin repeat domains, 11 of 
which are translocated by the Legionella 
Dot/Icm T4SS (Pan et al., 2008; Voth et al., 
2009). However, Ank function has remained 
a mystery until a recent report by Luhrmann 
et al. (2010) examining Coxiella effector-
driven anti-apoptotic activity. Coxiella 
antagonizes intrinsic apoptotic death in 
macrophages (Voth et al., 2007) and pre-
vents cytochrome c release from mitochon-
rapid apoptosis in some cell types, such 
as dendritic cells (DCs; Nogueira et al., 
2009). Therefore, the authors hypoth-
esized that Coxiella AnkG would provide 
Legionella with a tool to inhibit DC apop-
tosis and allow replication. Mouse bone 
marrow-derived DCs were infected with 
Legionella expressing Coxiella AnkG, then 
assessed for apoptosis. Remarkably, adding 
AnkG to Legionalla’s effector repertoire 
reduced DC apoptosis by ∼40%. Infecting 
cells with Legionella producing truncated 
AnkG showed the p32-interacting region 
was required for inhibition of apoptosis, 
highlighting the functional importance 
of an effector binding to a host protein. 
Additionally, siRNA-mediated dampen-
ing of p32 expression reduced Legionella-
triggered DC apoptosis similar to AnkG 
production. Collectively, the experiments 
performed by Luhrmann et al. (2010) pro-
vide a mechanism of AnkG anti-apoptotic 
activity and demonstrate the use one patho-
gen’s effector to study another organism’s 
intracellular activity.
Luhrmann et al. (2010) provide the 
first glimpse into how a Coxiella effector 
interacts with a host protein to alter a dis-
tinct infection event (Figure 1). This study 
also further underscores the differences 
between Coxiella and Legionella. Despite 
similar T4SSs, the effector repertoires of 
these two pathogens are highly divergent 
yet required for each organism’s intrac-
ellular lifestyle. The intriguing results of 
Luhrmann et al. (2010) also foster some 
remaining questions about the mechanism 
of AnkG-mediated protection. First, does 
translocated AnkG traffic to mitochondria 
to initiate p32 interactions? AnkG could 
potentially bind to cytosolic p32, prevent-
ing proper localization and interaction 
with mitochondrial proteins. Second, is 
AnkG binding to p32 alone sufficient to 
inhibit cytochrome c release? Third, does 
AnkG influence death receptor-mediated 
extrinsic apoptosis? Finally, do other Anks 
contribute to AnkG activity? In their initial 
screen, the authors showed that AnkF pro-
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Perhaps AnkF works in concert with AnkG 
to fully protect host cells from death. This 
prediction is not unprecedented, as four 
Legionella anti-apoptotic effectors tar-
get different host proteins (Banga et al., 
2007; Ge et al., 2009). Luhrmann et al. 
(2010) have defined an important role 
for AnkG in Coxiella–host cell interactions 
and demonstrated elegant experimental 
approaches that will serve as a blueprint 
for functional characterization of other 
Coxiella Dot/Icm substrates. It will also 
be interesting to see if Legionella can be 
exploited to study Coxiella effectors that 
direct other processes such as phagolyso-
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Figure 1 | Coxiella modulation of apoptosis. Coxiella predictably secretes numerous effectors into the 
host cytosol that influence events including inhibition of extrinsic and intrinsic apoptosis and activation of 
Akt and Erk1/2. A newly described example is AnkG, which binds specifically to host p32, presumably 
causing reduced cytochrome c (cyt c) release, and supplies protection from intrinsic apoptosis.
